Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial
口服缬氨曲普罗酯治疗APOEε4/ε4纯合子早期阿尔茨海默病患者的临床疗效、安全性和影像学效应：III期随机、双盲、安慰剂对照、78周APOLLOE4试验结果
期刊:Drugs
影响因子:14.4
doi:10.1007/s40265-025-02250-5
Abushakra, Susan; Power, Aidan; Watson, David; Porsteinsson, Anton; Sabbagh, Marwan; MacSweeney, Emer; Cohen, Sharon; Boada Rovira, Mercè; Doraiswamy, P Murali; Liang, Earvin; Flint, Susan; Kesslak, J Patrick; McLaine, Rosalind; Albayrak, Adem; Schaefer, Jean; Yu, Jeremy; Tolar, Luke; Dickson, Sam; Hey, John A; Tolar, Martin
